- Advertisement -
Melbourne-based biotech PolyNovo (ASX: PNV) has confirmed it is in the box seat to take advantage of changes to the US health system being implemented by the Trump administration, helping to briefly drive the company’s shares 26 per cent higher in early trade.
Shares in PolyNovo resumed trading…
Click here to view the original article.

